Symptomatic therapy is not required
Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients
Patellar tendinitis is most common in people who participate in activities that require running or jumping
BPC-157: 0.5 mg daily (or 0.25 mg twice daily) TB-500: 2-2.5 mg twice weekly (loading phase) Duration: 4-6 weeks loading, then 2-4 weeks maintenance Maintenance TB-500: 2 mg once weekly Administration: Use separate syringes
In some embodiments, the formulation or composition has a viscosity of about 2 cP to about 250,000 cP, about 2 cP to about 100,000 cP, about 2 cP to about 50,000 cP, about 2 cP to about 25,000 cP, about 2 cP to about 10,000 cP, about 2 cP to about 5,000 cP, about 2 cP to about 1,000 cP, about 2 cP to about 500 cP, about 2 cP to about 250 cP, about 2 cP to about 100 cP, about 2 cP to about 90 cP, about 2 cP to about 80 cP, about 2 cP to about 70 cP, about 2 cP to about 60 cP, about 2 cP to about 50 cP, about 2 cP to about 40 cP, about 2 cP to about 30 cP, about 2 cP to about 20 cP, or about 2 cP to about 10 cP
